Market revenue in 2023 | USD 42.2 million |
Market revenue in 2030 | USD 66.7 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.36% in 2023. Horizon Databook has segmented the Argentina clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
The future healthcare improvements in Argentina are likely to have a positive impact on clinical trial businesses and help increase efficiency and keep costs under control. The new administration plans to make import processes easier and less expensive, and there are already a few draft projects in process working toward this end.
Moreover, the government is focusing on increasing the number of clinical trials in the country. In 2016, two of the country’s government departments—the Ministry of Health and National Administration of Drugs, Foods and Medical Devices (ANMAT)—announced that they would be working together to increase clinical trial activity in the region and the country.
Central to this objective is the fundamental role clinical research plays in development of new medicines for prevention, treatment, and cure of various diseases & illnesses. Growing focus on clinical trials is expected to boost the demand for clinical trials supply and logistics in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into Argentina clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account